Used in cancer treatment, particularly for solid tumors such as non-small cell lung cancer and gastric cancer. Shows activity in patients who have developed resistance to other platinum-based drugs like cisplatin. Designed to have lower toxicity and better tolerability, especially reducing kidney damage and nausea. Administered intravenously in clinical settings as part of chemotherapy regimens. Currently under investigation in clinical trials to determine full efficacy and long-term safety profile.